Ultragenyx Pharmaceutical Inc at Leerink Global Healthcare Conference Transcript
Good morning, everyone. I'm Joe Schwartz from the biopharma equity research team at Leerink Partners. It's my pleasure to host our chat with Ultragenyx. We have Eric Crombez, CMO of the company with us today. Thanks so much for joining us.
Great, and thanks for having me.
So maybe you can start us off with a brief overview of the company's recent events and your priorities for this year.
Sure thing. I'll start with our commercial success we've had led by Crysvita. So certainly, a lot of continued growth there. Great to see double-digit growth year-over-year, along with Crysvita seeing really great growth with Dojolvi and Evkeeza specifically and also having MAbsvI there in the background.
So great background of commercial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
